Fractional carbon dioxide laser versus fractional Microneedle Radiofrequency in the Treatment of Post Burn Scars: a comparative randomized split scar study
- Disease/Condition
- Skin and Connective Tissue Diseases
- Intervention type
- device
- Primary sponsor
- Faculty of Medicine Cairo University Kasr AlAiny
- Funder
- Funded by the investigators
- Location
- Egypt
- Phase
- Phase 1
- Start date
- Jan 01, 1900
- End date
- Jan 01, 1900
Fractional Co2 laser resurfacing produces columns of thermal damage at specific depths (Manstein and Herron, 2004). The thermal effect stimulates a therapeutic wound healing response with heat – shock proteins, myofibroblasts, and an increased collagen III production, and therapy raises a potential for texture remodeling so that the appearance of burn scar will be improved (Luabach and tannous, 2006). Fractional microneedle radiofrequency (FMR) devices deliver energy to the deep dermis through insulated microneedles without destroying the epidermis (Kim et al., 2014). Fractional thermal injury of deep dermal collagen induced a vigorous wound healing process leading to dermal remodeling and the generation of new collagen and elastin (Alexiades-Armenakas et al., 2008).TGFβ1 stimulates growth and collagen secretion and is thought to be intergral to keloid formation (Peltonenet et al., 1991). It induces an increase in fibronectin bio synthesis, a link glycoprotein that binds to integrins and other matrix molecules, forming an early component of granulation tissue more rapidly in keloid fibroblasts, suggesting modification of this regulatory pathway (Ashcroft et al., 1999). Our current study aims at assessing the efficacy of fractional CO2 laser compared to fractional microneedle radiofrequency in the treatment of post burn scars, and the implications of both treatment modalities on TGFβ1 level. By this study, we hope to pave the way for optimum treatment strategies for patients with this disfiguring condition.
- Registry
- Pan Africa Clinical Trials Registry
- Trial ID
- PACTR202004808998657
- Type
- Device Trial
Access comprehensive clinical trial information for PACTR202004808998657 through Pure Global AI's free database. This Phase 1 trial is sponsored by Faculty of Medicine Cairo University Kasr AlAiny and is currently Completed. The study focuses on Skin and Connective Tissue Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.